Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 140

1.

Cancer incidence before and after kidney transplantation.

Vajdic CM, McDonald SP, McCredie MR, van Leeuwen MT, Stewart JH, Law M, Chapman JR, Webster AC, Kaldor JM, Grulich AE.

JAMA. 2006 Dec 20;296(23):2823-31.

PMID:
17179459
2.

Effect of reduced immunosuppression after kidney transplant failure on risk of cancer: population based retrospective cohort study.

van Leeuwen MT, Webster AC, McCredie MR, Stewart JH, McDonald SP, Amin J, Kaldor JM, Chapman JR, Vajdic CM, Grulich AE.

BMJ. 2010 Feb 11;340:c570. doi: 10.1136/bmj.c570.

3.

Increased incidence of squamous cell carcinoma of eye after kidney transplantation.

Vajdic CM, van Leeuwen MT, McDonald SP, McCredie MR, Law M, Chapman JR, Webster AC, Kaldor JM, Grulich AE.

J Natl Cancer Inst. 2007 Sep 5;99(17):1340-2. Epub 2007 Aug 14.

PMID:
17698951
4.

Cancer incidence among Canadian kidney transplant recipients.

Villeneuve PJ, Schaubel DE, Fenton SS, Shepherd FA, Jiang Y, Mao Y.

Am J Transplant. 2007 Apr;7(4):941-8. Epub 2007 Feb 28.

5.

Cutaneous melanoma is related to immune suppression in kidney transplant recipients.

Vajdic CM, van Leeuwen MT, Webster AC, McCredie MR, Stewart JH, Chapman JR, Amin J, McDonald SP, Grulich AE.

Cancer Epidemiol Biomarkers Prev. 2009 Aug;18(8):2297-303. doi: 10.1158/1055-9965.EPI-09-0278. Epub 2009 Jul 21.

6.

Immunosuppression and other risk factors for lip cancer after kidney transplantation.

van Leeuwen MT, Grulich AE, McDonald SP, McCredie MR, Amin J, Stewart JH, Webster AC, Chapman JR, Vajdic CM.

Cancer Epidemiol Biomarkers Prev. 2009 Feb;18(2):561-9. doi: 10.1158/1055-9965.EPI-08-0919. Epub 2009 Feb 3.

7.

Spectrum of cancer risk among US solid organ transplant recipients.

Engels EA, Pfeiffer RM, Fraumeni JF Jr, Kasiske BL, Israni AK, Snyder JJ, Wolfe RA, Goodrich NP, Bayakly AR, Clarke CA, Copeland G, Finch JL, Fleissner ML, Goodman MT, Kahn A, Koch L, Lynch CF, Madeleine MM, Pawlish K, Rao C, Williams MA, Castenson D, Curry M, Parsons R, Fant G, Lin M.

JAMA. 2011 Nov 2;306(17):1891-901. doi: 10.1001/jama.2011.1592.

8.

Validity of registry data: agreement between cancer records in an end-stage kidney disease registry (voluntary reporting) and a cancer register (statutory reporting).

Webster AC, Supramaniam R, O'Connell DL, Chapman JR, Craig JC.

Nephrology (Carlton). 2010 Jun;15(4):491-501. doi: 10.1111/j.1440-1797.2010.01297.x.

PMID:
20609104
9.

ESRD in Australia and New Zealand at the end of the millennium: a report from the ANZDATA registry.

McDonald SP, Russ GR, Kerr PG, Collins JF; Australia and New Zealand Dialysis and Transplant Registry.

Am J Kidney Dis. 2002 Dec;40(6):1122-31.

PMID:
12460029
10.

The pattern of excess cancer in dialysis and transplantation.

Stewart JH, Vajdic CM, van Leeuwen MT, Amin J, Webster AC, Chapman JR, McDonald SP, Grulich AE, McCredie MR.

Nephrol Dial Transplant. 2009 Oct;24(10):3225-31. doi: 10.1093/ndt/gfp331. Epub 2009 Jul 8.

PMID:
19589786
11.

Italian cancer figures, report 2013: Multiple tumours.

AIRTUM Working Group.

Epidemiol Prev. 2013 Jul-Oct;37(4-5 Suppl 1):1-152. English, Italian.

12.

[The Veneto Region's Registry of Dialysis and Transplantation: 2006-2007 report].

Antonucci F, Camerin E, Feriani M, Nordio M, Piccoli A, Rossi B, Tessitore N.

G Ital Nefrol. 2009 Nov-Dec;26 Suppl 48:S5-56. Italian.

PMID:
19927265
14.

[REIN Report 2011--summary].

Couchoud C, Lassalle M, Jacquelinet C.

Nephrol Ther. 2013 Sep;9 Suppl 1:S3-6. doi: 10.1016/S1769-7255(13)70036-1. French.

PMID:
24119584
15.

Cancer incidence among US Medicare ESRD patients receiving hemodialysis, 1996-2009.

Butler AM, Olshan AF, Kshirsagar AV, Edwards JK, Nielsen ME, Wheeler SB, Brookhart MA.

Am J Kidney Dis. 2015 May;65(5):763-72. doi: 10.1053/j.ajkd.2014.12.013. Epub 2015 Feb 7.

16.

Effect of immunosuppression for primary renal disease on the risk of cancer in subsequent renal transplantation: a population-based retrospective cohort study.

Hibberd AD, Trevillian PR, Wlodarczyk JH, Kemp DG, Stein AM, Gillies AH, Heer MK, Sheil AG.

Transplantation. 2013 Jan 15;95(1):122-7. doi: 10.1097/TP.0b013e3182782f59.

PMID:
23238532
17.

Cancer in patients on dialysis for end-stage renal disease: an international collaborative study.

Maisonneuve P, Agodoa L, Gellert R, Stewart JH, Buccianti G, Lowenfels AB, Wolfe RA, Jones E, Disney AP, Briggs D, McCredie M, Boyle P.

Lancet. 1999 Jul 10;354(9173):93-9.

PMID:
10408483
18.

End-stage kidney disease due to Alport syndrome: outcomes in 296 consecutive Australia and New Zealand Dialysis and Transplant Registry cases.

Mallett A, Tang W, Clayton PA, Stevenson S, McDonald SP, Hawley CM, Badve SV, Boudville N, Brown FG, Campbell SB, Johnson DW.

Nephrol Dial Transplant. 2014 Dec;29(12):2277-86. doi: 10.1093/ndt/gfu254. Epub 2014 Jul 24.

PMID:
25061124
19.

Cancer risks after solid organ transplantation and after long-term dialysis.

Hortlund M, Arroyo Mühr LS, Storm H, Engholm G, Dillner J, Bzhalava D.

Int J Cancer. 2017 Mar 1;140(5):1091-1101. doi: 10.1002/ijc.30531.

20.

Estimating the total incidence of kidney failure in Australia including individuals who are not treated by dialysis or transplantation.

Sparke C, Moon L, Green F, Mathew T, Cass A, Chadban S, Chapman J, Hoy W, McDonald S.

Am J Kidney Dis. 2013 Mar;61(3):413-9. doi: 10.1053/j.ajkd.2012.10.012. Epub 2012 Nov 21.

PMID:
23177731

Supplemental Content

Support Center